501 related articles for article (PubMed ID: 9926915)
1. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription.
Sieber T; Dobner T
J Virol; 2007 Jan; 81(1):95-105. PubMed ID: 17050591
[TBL] [Abstract][Full Text] [Related]
3. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
4. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.
Steegenga WT; Riteco N; Jochemsen AG; Fallaux FJ; Bos JL
Oncogene; 1998 Jan; 16(3):349-57. PubMed ID: 9467960
[TBL] [Abstract][Full Text] [Related]
5. Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein.
Nevels M; Rubenwolf S; Spruss T; Wolf H; Dobner T
J Virol; 2000 Jun; 74(11):5168-81. PubMed ID: 10799592
[TBL] [Abstract][Full Text] [Related]
6. Transforming potential of the adenovirus type 5 E4orf3 protein.
Nevels M; Täuber B; Kremmer E; Spruss T; Wolf H; Dobner T
J Virol; 1999 Feb; 73(2):1591-600. PubMed ID: 9882365
[TBL] [Abstract][Full Text] [Related]
7. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
8. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function.
Nevels M; Rubenwolf S; Spruss T; Wolf H; Dobner T
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1206-11. PubMed ID: 9037031
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic potential of the adenovirus E4orf6 protein.
Moore M; Horikoshi N; Shenk T
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11295-301. PubMed ID: 8876129
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the E1a gene of type 5 adenovirus result in oncogenic transformation of Fischer rat embryo cells.
Duigou GJ; Babiss LE; Liaw WS; Zimmer SG; Ginsberg HS; Fisher PB
J Cell Biochem; 1987 Feb; 33(2):117-26. PubMed ID: 3571338
[TBL] [Abstract][Full Text] [Related]
11. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
Shen Y; Kitzes G; Nye JA; Fattaey A; Hermiston T
J Virol; 2001 May; 75(9):4297-307. PubMed ID: 11287579
[TBL] [Abstract][Full Text] [Related]
12. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
Hobom U; Dobbelstein M
J Virol; 2004 Jul; 78(14):7685-97. PubMed ID: 15220443
[TBL] [Abstract][Full Text] [Related]
13. Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cells.
Hutton FG; Turnell AS; Gallimore PH; Grand RJ
Oncogene; 2000 Jan; 19(3):452-62. PubMed ID: 10656694
[TBL] [Abstract][Full Text] [Related]
14. Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells.
Duigou GJ; Su ZZ; Babiss LE; Driscoll B; Fung YK; Fisher PB
Oncogene; 1991 Oct; 6(10):1813-24. PubMed ID: 1923506
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.
Härtl B; Zeller T; Blanchette P; Kremmer E; Dobner T
Oncogene; 2008 Jun; 27(26):3673-84. PubMed ID: 18212738
[TBL] [Abstract][Full Text] [Related]
16. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression.
Su ZZ; Lin J; Grunberger D; Fisher PB
Cancer Res; 1994 Apr; 54(7):1865-70. PubMed ID: 7511055
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of wild-type p53 and c-Myc in human fetal cells transformed with adenovirus early region 1.
Grand RJ; Lecane PS; Roberts S; Grant ML; Lane DP; Young LS; Dawson CW; Gallimore PH
Virology; 1993 Apr; 193(2):579-91. PubMed ID: 8460477
[TBL] [Abstract][Full Text] [Related]
19. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
Savelyeva I; Dobbelstein M
Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
[TBL] [Abstract][Full Text] [Related]
20. Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA.
Yamano S; Tokino T; Yasuda M; Kaneuchi M; Takahashi M; Niitsu Y; Fujinaga K; Yamashita T
J Virol; 1999 Dec; 73(12):10095-103. PubMed ID: 10559324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
